Adesão do portador de transtorno mental à terapêutica medicamentosa no tratamento em saúde mental

Borba, Letícia de Oliveira; Maftum, Mariluci Alves; Vayego, Stela Adami; Mantovani, Maria de Fátima; Félix, Jorge Vinícius Cestari; Kalinke, Luciana Puchalski

doi:10.1590/s1980-220x2017006603341

Cited by 15 publications

(17 citation statements)

References 19 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…32,33 In mental health patients, the lack of insight about the disease, the complexity of the therapeutic regimen, a lack of family support, side effects, the belief that the medication is ineffective, the difficulty of medication access and remembering to take the medicine are predictors of poor adherence. [34][35][36][37] So, nonadherence to medication among patients with mental disorders must be prevented, avoiding negative clinical and economic consequences in these patients. [38][39][40] In the present study, PFS improves the adherence of treatment over the course of pharmaceutical consultations.…”

Section: Discussionmentioning

confidence: 99%

Pharmacotherapy Follow up in Mental Health: Which Outcomes Change in a Short Period?

Fernandes¹,

Brito²,

Rocha³

et al. 2020

JYP

View full text Add to dashboard Cite

Objectives: Investigate the outcome changes in patients with depression and anxiety during a pharmacotherapy follow up service, in a short period. Materials and Methods: A randomized and controlled trial of 70 adults was developed in Psychosocial Care Centers in Brazil. Patients in the intervention group received pharmacotherapy follow up service according over a 4-month period. The control group received traditional service. After the 4-month period, patients of the control group were invited to participate for another four months receiving pharmacotherapy follow up service (control group post-intervention). The primary outcomes (medication adherence, anxiety and depression rates, quality of life) and the variations between groups were compared. Results: The evaluation of the control group data showed no statistically significant difference for parameters. However, in relation to adherence to pharmacotherapy, there was a statistically significant difference in the intervention group, between consultations 1 and 3 and consultations 1 and 4. For the clinical parameters (depression and anxiety) and humanistic (quality of life), there was no difference between the intervention group consultations. For the patients in the control group post-intervention (consultations 1 to 4), when compared to moment 4 of the control group, the levels of depression decreased between the moment 4 control group and the moments of the pharmaceutical appointment 2, 3 and 4. Conclusion: This study points out that these patients should take much more time being followed up, in order to improve the clinical and humanistic outcomes. Also, standardized documentation and records have to be provided in this pharmaceutical service.

show abstract

Section: Discussionmentioning

confidence: 99%

Pharmacotherapy Follow up in Mental Health: Which Outcomes Change in a Short Period?

Fernandes¹,

Brito²,

Rocha³

et al. 2020

JYP

View full text Add to dashboard Cite

show abstract

“…Factors commonly associated with mental disorders include not only individual attributes but also social, cultural, economic, political and environmental factors, and between 76 and 85% of people with mental disorders in low- and middle-income countries do not receive any kind of treatment (Goldberg and Huxley, 1992 ). The high number of low- and middle-income people who do not receive treatment can be justified because the individual needs to have access to the medication, and the lack of financial resources for its acquisition restricts or makes this access impossible, compromising the follow-up of the treatment of the mental disorder (Borba et al, 2018 ).…”

Section: Introductionmentioning

confidence: 99%

Factors Associated With Mental Suffering in the Brazilian Population: A Multilevel Analysis

et al. 2021

View full text Add to dashboard Cite

Purpose: To analyze how individual characteristics and the social context are associated with mental distress symptoms in the Brazilian population.Method: A multilevel cross-sectional study with data from the 2013 National Health Survey. There were two dependent variables: (a) decreased vital energy and somatic symptoms, (b) the presence of depressive thoughts. The independent variables were biological characteristics, education and income, habits and lifestyle, and context variables. Bivariate analysis was performed, and Prevalence Ratios calculated in a Poisson Regression (95% CI). A multilevel Poisson Regression was performed to verify the effect of individual and contextual variables.Results: Regarding depressive thoughts, young and middle-aged individuals, low education, women, absence of partner, smokers or former smokers, and absence of health insurance were the categories at highest risk; belonging to classes D-E and living in states with lower expected years of schooling proved to be protective factors. Similar results were found for the second outcome.Conclusions: Symptoms of mental distress were associated with the individual characteristics and contextual aspects of the federation unit. These findings indicate the importance of strengthening psychosocial care aimed at vulnerable groups.

show abstract

“…A depender da gravidade, esse transtorno requer tratamento medicamentoso para o controle dos sintomas, sendo necessário que o mesmo seja realizado de forma continuada por tempo variável após a remissão das manifestações mais comuns da doença (Razzouk, 2016;Borba et al, 2018).…”

Section: Introductionunclassified

“…A prescrição medicamentosa deve estar aliada a uma série de fatores comportamentais que dizem respeito aos hábitos de vida e de como a terapia é considerada, no entanto, a maior parte dos pacientes que recebe prescrição de antidepressivos interrompe prematuramente o tratamento ou o conduz de forma inconsistente (Borba et al, 2018). A falta de adesão a terapêutica destaca-se como fator potencialmente modificável que pode precipitar recaídas e refratariedade farmacológica (Cardoso, Byrne, & Xavier, 2016).…”

Section: Introductionunclassified

Análise retrospectiva do paciente com depressão assistido em serviço especializado de saúde mental

Neto

Sidrim

Feitosa

et al. 2021

RSD

View full text Add to dashboard Cite

Objetivo: descrever a aplicação da análise retrospectiva do paciente com depressão assistido em serviço especializado de saúde mental à luz do cuidado de enfermagem. Metodologia: Pesquisa descritiva com abordagem qualitativa e retrospectiva, desenvolvida em um serviço da rede de atenção psicossocial em uma cidade do interior cearense, no período de abril a maio de 2019, por meio de entrevista e levantamento do histórico do paciente. Resultados: Observou-se que traumas relacionados ao histórico do paciente pessoal e familiar são presentes na fala e repercutem nas atividades de vida diárias e agravamento do quadro clinico. A presença de alucinações auditivas e pensamentos suicidas revelaram necessidade de cuidados específicos. Os diagnósticos elencados foram: Confusão crônica; Interação social prejudicada; Disposição para processos familiares melhorados; Síndrome pós trauma; Medo; Disposição para bem-estar espiritual melhorado; Risco de Suicídio. Conclusão: Ressalta-se que a efetividade do atendimento multiprofissional se relaciona com a abordagem retrospectiva do paciente e o cuidado ao indivíduo de forma biopsicossocial, especialmente à luz do cuidado de enfermagem.

show abstract

Adesão do portador de transtorno mental à terapêutica medicamentosa no tratamento em saúde mental

Cited by 15 publications

References 19 publications

Pharmacotherapy Follow up in Mental Health: Which Outcomes Change in a Short Period?

Pharmacotherapy Follow up in Mental Health: Which Outcomes Change in a Short Period?

Factors Associated With Mental Suffering in the Brazilian Population: A Multilevel Analysis

Análise retrospectiva do paciente com depressão assistido em serviço especializado de saúde mental

Contact Info

Product

Resources

About